Department of Public Health
University of
Helsinki,
Finland
harri.hemila@helsinki.fi
http://www.mv.helsinki.fi/home/hemila
Jan
31, 2025
On
Jan 2025,
this review had the Altmetric score 4427
https://cochrane.altmetric.com/details/1229303
On Oct 2022, this review had the Altmetric score 3382,
which was position 1439 out of all the 22,246,158 outputs, and 5th of
the Cochrane
reviews:
https://www.mv.helsinki.fi/home/hemila/AltmetricVitC_Colds_2022Oct.htm#score
Cochrane
Database Syst Rev 2013;
CD000980
https://pmc.ncbi.nlm.nih.gov/articles/PMC8078152
https://hdl.handle.net/10138/225864
https://doi.org/10.1002/14651858.cd000980.pub4
https://www.mv.helsinki.fi/home/hemila/CC/2013_Coch_Colds_CD000980.pdf
https://www.ncbi.nlm.nih.gov/pubmed/23440782
References
to the
review:
https://www.mv.helsinki.fi/home/hemila/CC
Commentaries
on ‘Vitamin C for Preventing and Treating the Common Cold’ with a
response from the review author
[Reply to Bax, Spee and Madderom].
[Reply to Shamseer and Vohra].
Evidence-Based Child Health: A Cochrane Review Journal
2008;3:724-728
https://www.researchgate.net/publication/244785237
https://hdl.handle.net/10138/228088
https://doi.org/10.1002/ebch.261
https://www.mv.helsinki.fi/home/hemila/H/2008_L_EBCH.pdf
Three controlled trials have found
significant decrease in the incidence of pneumonia and two found
treatment benefit for pneumonia patients.
Hemilä H,
Louhiala P.
Vitamin C for preventing and treating pneumonia.
Cochrane Database Syst Rev 2013;
CD005532
https://hdl.handle.net/10138/225862
https://www.mv.helsinki.fi/home/hemila/CP/2013_Coch_Pneu_CD005532.pdf
https://doi.org/10.1002/14651858.cd005532.pub3
https://pubmed.ncbi.nlm.nih.gov/23925826/
References to the
review:
https://www.mv.helsinki.fi/home/hemila/CP/
Hemilä H, Koivula TT
Vitamin C for preventing and
treating tetanus.
Cochrane Database Syst Rev 2013;
CD006665
https://hdl.handle.net/10138/225863
https://doi.org/10.1002/14651858.cd006665.pub3
https://www.mv.helsinki.fi/home/hemila/CT/2013_Coch_Tetanus_CD006665.pdf
https://pubmed.ncbi.nlm.nih.gov/24226506/
References to the
review:
https://www.mv.helsinki.fi/home/hemila/CT/
Cochrane review on zinc and the common cold (2024) had a very large number of flaws:
Hemilä H, Chalker E.
Shortcomings in the Cochrane review
on zinc for the common cold (2024).
Front Med (Lausanne).
2024
https://doi.org/10.3389/fmed.2024.1470004
https://pmc.ncbi.nlm.nih.gov/articles/PMC11521859
Longer version describing the details of the flaws:
Hemilä H.
Shortcomings in the Cochrane review on zinc and
the common cold by Nault et al. (2024).
Zenodo.
https://doi.org/10.5281/zenodo.13762569
##########################################
Cochrane has not consistently followed
the COPE guidelines - THERE WAS NO RESPONSE TO THIS
CRITICISM
Eur J Clin Invest
2020
https://doi.org/10.1111/eci.13216
https://pubmed.ncbi.nlm.nih.gov/32077498
##########################################
Flaws in a 2020 Cochrane review on
vitamin C and pneumonia:
Hemilä
H, Chalker E.
Commentary:
Vitamin C supplementation for prevention and treatment of
pneumonia.
Front
Med
2021
https://doi.org/10.3389/fmed.2020.595988
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7854566/
##########################################
Pointing out errors in the Cochrane
review and a meta-analysis of 3 exercise-induced asthma trials
The
meta-analysis was expanded to BMJ Open paper in 2013
The
Cochrane review on vitamin C and asthma misled readers for a decade
from 2001 to 2013
Hemilä
H. Feedback [on the Cochrane review “vitamin C supplementation
for asthma” (2009) by Kaur B, Rowe BH, Stovold E]
Cochrane
Database of Systematic Reviews CD000993 [Feedback 24 March
2009]
https://helda.helsinki.fi/handle/10138/38500
https://doi.org/10.13140/2.1.1280.3364
The above comment was submitted in 2009, but the authors replied no
earlier than in 2012.
Furthermore, the reply
was full of errors:
Hemilä H
Vitamin C and exercise-induced bronchoconstriction:
further problems in the Cochrane review "vitamin C for asthma"
(2013).
Unpublished commentary
http://hdl.handle.net/10138/40816
The
Cochrane review on vitamin C and asthma misled readers for a decade
from 2001 to 2013.
See
the PubMed records of the Cohrane review on vitamin C and asthma from
2001 to 2013:
https://pubmed.ncbi.nlm.nih.gov/11687089/
2001
https://doi.org/10.1002/14651858.CD000993
ss
https://pubmed.ncbi.nlm.nih.gov/15266435/
2004
https://doi.org/10.1002/14651858.CD000993.pub2
https://pubmed.ncbi.nlm.nih.gov/19160185/
2009
https://doi.org/10.1002/14651858.CD000993.pub3
https://pubmed.ncbi.nlm.nih.gov/24155047/
2013 Withdrawal of the
Cochrane review
https://doi.org/10.1002/14651858.CD000993.pub4
##########################################
Hemilä H
Oseltamivir (Tamiflu) shortens the duration of
influenza-like illness by 13% (95% CI: 8% to 18%)
[Feedback
on the Cochrane review “Neuraminidase inhibitors for preventing and
treating influenza in healthy adults and children” by Jefferson T
et al.]
Cochrane Database of Systematic Reviews CD008965
[Feedback 6 May
2013]
https://helda.helsinki.fi/handle/10138/42534
https://doi.org/10.1002/14651858.CD008965.pub3
##########################################
Problems in the 2011 version of Cochrane
review:
Hemilä H.
The zinc for the
common cold review by Singh and Das has a number of problems which
should be considered when the review is next time updated.
[Feedback
on the Cochrane review “Zinc for the common cold review”
by Singh and Das]. 2011.
Cochrane Database of Systematic Reviews
CD001364 [Feedback 5 September 2011]
Repository of the
University of
Helsinki
https://helda.helsinki.fi/handle/10138/39188
https://doi.org/10.13140/2.1.4688.2081
Problems in the 2013 version of Cochrane
review:
Hemilä H.
Concerns about
unattributed copying of text and data, and about numerous other
problems in the Cochrane review “Zinc for the Common Cold” by
Singh M, Das RR (2013). 2015
Repository of the University of
Helsinki
https://hdl.handle.net/10138/153180
https://doi.org/10.5281/zenodo.6394116
The above comment led to the withdrawal of the Cochrane review,
see:
https://www.cochrane.org/CD001364/ARI_zinc-common-cold
https://doi.org/10.1002/14651858.CD001364.pub5
The withdrawal of the Cochrane review also led to the
retraction of a JAMA summary of the Cochrane review:
Hemilä H.
Common Cold Treatment Using Zinc.
JAMA.
2015;314(7):730.
https://doi.org/10.1001/jama.2015.8174
https://www.ncbi.nlm.nih.gov/pubmed/26284728
The above JAMA letter pointed out
problems in an article by Das and Singh, which was a summary of their
Cochrane review.
As their Cochrane review was
withdrawn, their JAMA article was
retracted:
https://doi.org/10.1001/jama.2016.18134
https://www.ncbi.nlm.nih.gov/pubmed/28027374
More detailed problems in the Das and Singh JAMA article were
described in a longer document:
https://hdl.handle.net/10138/153617
https://doi.org/10.5281/zenodo.6393782
##########################################
Hemilä H
Antioxidants are not identical and their effects
are not uniform over the population.
[Feedback on the
Cochrane review “Antioxidant supplements for prevention of
mortality in healthy participants and patients with various diseases”
by Bjelakovic G et al.]
Cochrane Database of Systematic Reviews
CD007176 [Feedback 24 August 2009]
https://helda.helsinki.fi/handle/10138/136201
https://doi.org/10.13140/2.1.4426.0641
https://doi.org/10.1002/14651858.CD007176.pub2